Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Post by yopmemama021on Aug 03, 2021 5:10pm
161 Views
Post# 33646020

IPOT

IPOT

ESE 

 

IPOT was up 6.5% today , mc $23.93 M trading over 3X average volume 

 

limited supply being that isracann is the first  ever pure-play cannabis firm in Israel - and enormous demand considering the country has the highest highest cannabis use per capita in the world. (~27%) 

 

The underserved domestic market presents significant and immediate opportunity for $IPOT 

 

Israel has all around optimal climatic conditions from humidity, temperature and sunlight,   to organically grow medical cannabis with the lowest possible production costs.

 

EU medical market estimated to be $64B USD by 2028.

 

<< Previous
Bullboard Posts
Next >>